News

  • Endometriosis-sufferer wins landmark tribunal case on workplace discrimination

    A former Accenture employee has won an appeal tribunal ruling after a judge said her endometriosis may amount to a disability under the Equality Act 2010. A senior employment law judge last month quashed a 2022 tribunal decision that rejected claims brought by Sanju Pal, 43, against the consulting firm. The judge found the original [...]

  • State abortion bans linked to spike in maternal deaths, study finds

    Abortion restrictions in US states were linked to higher maternal deaths during pregnancy and within 42 days after birth, a new study suggests. The research examined links between different abortion restrictions introduced across US states between 2005 and 2023 and deaths during pregnancy or in the first 42 days after giving birth. Unlike much earlier [...]

  • Women make up almost 80% of weight loss jab prescriptions

    Almost 80 per cent of private weight loss jabs such as Mounjaro are prescribed to women, according to analysis of 113,630 patients. The analysis, covering private prescriptions issued between November 2024 and October 2025, found take-up was concentrated among women and middle-class patients. Uptake was highest in those aged 30 to 49 and dropped sharply [...]

  • Childhood abuse may leave gene activity changes linked to depression

    Childhood abuse may alter gene activity in some women, raising depression risk, UK Biobank analysis suggests. The pattern was not seen in men, suggesting the biological links between trauma and depression may differ by sex, an area of interest given higher depression rates among women. Using data from thousands of people in the UK Biobank, [...]

  • Study reveals how bacteria can promote breast cancer

    Harmful bacteria may worsen breast cancer by switching on an enzyme that damages DNA and helps tumours grow, researchers say. The study found that pathogenic bacteria seen in gut and breast tissue, including Bacteroides fragilis, Fusobacterium nucleatum and Escherichia coli, boosted activity of spermine oxidase (SMOX). This rise was linked to DNA damage, tumour growth [...]

  • GenM expands to Australian market

    GenM is taking its menopause certification to Australia with TerryWhite Chemmart, Australia’s largest pharmacy network. The tie-up marks the first time GenM’s MTick menopause-friendly shopping symbol and certification has been rolled out at national scale outside the UK. It is GenM’s largest international expansion to date. The MTick certification will be introduced across [...]

  • Matresa raises £315k for maternal health platform

    Matresa has raised £315k in pre-seed funding to build a maternal health platform offering personalised screening and support in the UK. The funding comes as maternal deaths in the UK are at their highest level in more than 20 years, according to the company. Founded by former nurse Mari-Carmen Sanchez-Morris, Matresa is developing a platform [...]

  • Embryos saved after patients win high court consent case

    More than a dozen fertility patients have won a High Court battle to save their embryos, eggs and sperm from destruction after paperwork mistakes. The ruling followed errors that meant patients did not renew consent to store their biological material within the 10-year window required by law. In some cases, fertility clinics failed to notify [...]

  • Is your fertility innovation award-worthy?

    If you've been asking yourself whether your fertility innovation deserves a place among the Femtech World Awards nominees, understanding what judges value can help you see your work through their eyes. Ultimately, the judges are seeking solutions that demonstrate genuine impact on people's fertility journeys. This means your innovation should address a real and significant [...]

  • Magseed Marker included in new SE08 dossier to support localisation funding in France

    As of January 2026, the French health authorities have created a new "Safety and Environment Package" for hospitals (Package SE8), which includes the Magseed marker for €390.16 - as outlined in the 2026 Medical Care/Home Hospitalization (MCO/HAD) Service and Tariff Orders published on January 13, 2026 (Order of June 12, 2026, Appendix 11). This new [...]